Pulmonary hypertension in a patient with hereditary haemorrhagic telangiectasia

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Chadha, Davinder ^a   Handa, Ajay ^b   Kumar, Abhishek ^c  

^a MH ^*  (India)

^b BASE HOSPITAL   (India)

^c Military Hospital Barrackpore   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE INCREASE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; THORAX RADIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 84874668713     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-008352     Document Type: Article

References (14)

1. Rendu H. Epistaxis repetees chez un sujet porteur de petits angiomes cutanes et muquez. Gaz Hôpitaux 1896;13:1322-3.
2. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bull Johns Hopkins Hosp 1901;12:333-7.
3. Weber F. Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring hemorrhages. Lancet 1907;2:160-2.
4. Olitsky SE. Hereditary hemorrhagic telangiectasia: diagnosis and management. Am Fam Physician 2010;82:785-90.
5. Faughnan ME, Granton JT, Young LH. The pulmonary vascular complications of hereditary haemorrhagic telangiectasia. Eur Respir J 2009;33:1186-94.
6. Simonneau G, Robbins I, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
7. Raimondi A, Blanco I, Pomares X, et al. Pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia. Arch Bronconeumol 2012 Jun 22 (Epub ahead of print) PMID: 22727716.
8. Rigelsky CM, Jennings C, Lehtonen R, et al. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Am J Med Genet A 2008;146A:2551-6.
9. Ayala E, Kudelko KT, Haddad F, et al. The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure. Chest 2012;141:1598-600.
10. Cottin V, Dupuis-Girod S, Lesca G, et al. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler disease). Respiration 2007;74:361-78.
11. Reichenberger F, Wehner LE, Breithecker A, et al. Pulmonary hypertension in hereditary haemorrhagic teleangiectasia. Pneumologie 2009;63:669-74.
12. Chang SA, Jang SY, Ki CS, et al. Successful bosentan therapy for pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Heart Vessels 2011;26:231-4.
13. Providência R, Mdo C Cachulo, Costa GV, et al. Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension. Arq Bras Cardiol 2010;94:e34-6, e94-6.
14. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.